The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma
The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma
About this item
Full title
Author / Creator
Publisher
Dordrecht: Springer Netherlands
Journal title
Language
English
Formats
Publication information
Publisher
Dordrecht: Springer Netherlands
Subjects
More information
Scope and Contents
Contents
Poor prognosis of lung adenocarcinoma is associated with early occurrence of distant metastases. This type of non-small-cell lung carcinoma more frequently involves
EGFR
gene abnormalities, which determine the efficacy of EGFR tyrosine kinase inhibitor therapies (EGFR TKIs). It is probable that genetic abnormalities present in primary tumor w...
Alternative Titles
Full title
The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3889871
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3889871
Other Identifiers
ISSN
1219-4956
E-ISSN
1532-2807
DOI
10.1007/s12253-013-9667-4
